Join to View Full Profile
15 Parkman St# WangBoston, MA 02114
Phone+1 617-726-4530
Fax+1 617-726-6131
Dr. Blute is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 1982 - 1987
Creighton University School of MedicineClass of 1982
Certifications & Licensure
MA State Medical License 2010 - 2027
ME State Medical License 2020 - 2021
RI State Medical License 2020 - 2020
MN State Medical License 1983 - 2011
FL State Medical License 1990 - 1996
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
- High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer Start of enrollment: 1999 Oct 01
Publications & Presentations
PubMed
- Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell Carcinoma.Yihan Cao, Jonathan Kim, Justin Talluto, Taylor McVeigh, Michael L Blute
Pharmaceutics. 2026-02-19 - 2 citationsPSA density as a dynamic prognostic marker of biopsy grade progression during active surveillance.Andrew Gusev, Florian Rumpf, Dimitar Zlatev, Jeffrey K Twum-Ampofo, John L Gore
Urologic Oncology. 2025-12-01 - 5 citationsA contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma.Edouard Nicaise, Adam S Feldman, Andrew Gusev, Alice Yu, Naren Nimmagadda
BMC Urology. 2024-03-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
